eupolicy.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
This Mastodon server is a friendly and respectful discussion space for people working in areas related to EU policy. When you request to create an account, please tell us something about you.

Server stats:

239
active users

A thing I have noticed. 2 decades ago, there was decent pharmaceutical knowledge in the trans community. We knew what GnRH agonists were and how they work. We knew that for trans girls, if you couldn’t get them, then a cocktail of spironolactone and finasteride would do a pretty good job as a replacement. We knew that cyproterone acetate worked even better than spiro, but was hepatotoxic, so be careful.

I feel like that’s all been … lost?

I suspect that until this sentence, most currently transitioning people won’t even know that GnRH agonist is the proper term for what is frequently and misleadingly called a “puberty blocker”.

How did we let all this knowledge get lost? We, as a community, used to know how to outflank attempts to stop us accessing medication.

Now the British government just go, “we’re banning prescription of puberty blockers” and everyone throws their hands up and goes, “oh well, no alternative but unopposed testosterone I guess”.

We were better than this. Why did that go away?

Llwynog

@goatsarah It's possible to genetically modify gonads IN ADULTS so they produce desired levels of T or O. It's not even that difficult (for trans men, it would involve a one-off tamoxifen injection directly into the ovaries). As soon as the trans community figures out how to use genetic engineering, governments will find it nearly impossible to stop us: onlinelibrary.wiley.com/doi/10